Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm

Yesterday, Paxman's CEO Richard Paxman visited Stora Aktiedagen in Stockholm. Stakeholders were given the opportunity for a presentation of the company and updates on the company's operations and development. Now the presentation is available in its entirety to take part digitally.

The presentation and subsequent question and answer session with CEO Richard Paxman was recorded and can be viewed through the following link:
https://youtu.be/9l_hYtZjLrY?si=FSHOMRoBQTebSdIb

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 5,000 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK), Houston, Texas (US) and Toronto, Ontario (CA).

The PAXMAN share is listed on Nasdaq First North Growth Market.
FNCA Sweden AB is the company’s Certified Adviser.

Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm

Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm

What we do

Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.

Learn more →

Financial Information

Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.

Read reports →

Investing in Paxman

Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.

Visit the Investor Centre →

Stay in the loop

Contact

Paxman Coolers Limited
International House, Penistone Road
Fenay Bridge, Huddersfield
West Yorkshire, UK
HD8 0LE

Paxman AB (publ)
Pirgatan 13
SE-374 35 KARLSHAMN
Sweden

IR Contact

IR Contact
Emelie Gustafsson, CFO
Tel +46 (0)70 – 454 37 91
Email: emelie.gustafsson@paxman.se